You are here
Development of Smart Phone-based Automated Microfluidic-ELISA For Human Immunodefciency Virus 1
- Date Issued:
- 2017
- Summary:
- The majority of HIV prevalence is found in Sub-Saharan Africa with 36.9 mil- lion living with HIV/AIDS. The cultural implications such as patient non-compliance or denial of available routine medical care can potentially cause limitations on the ef- fectiveness of detecting such virulent pathogens and manage chronic disease. The lack of access to healthcare and further socioeconomic impacts hinder the ability to ade- quately diagnose and treat infection in resource-limited settings. Intervention through diagnosis and treatment helps prevent the spread of transmission, where pre-exposure prophylaxis or active disease prevention measures are not readily available. The cur- rent gold standard for HIV detection is by molecular detection; Reverse-Transcription Polymerase Chain Reaction is widely used that employs cycles of temperature condi- tions that require a thermal cycling platform and typically laboratory space for RNA extraction separate from RT-PCR space required. Serological detection can be ad- vantageous for surveillance and screening, Lateral Flow Assays and Enzyme-Linked Immunosorbent Assay (ELISA) can detect a viral protein (antigen) or antibodies. The ELISA can require at least 12 hours of assay preparation and takes a diagnostic laboratory many resources to run. There is need to develop Point-of-Care (POC) testing that can potentially be used for decentralized testing that can leverage ex- isting technologies such as smart phone capability and routine medical or diagnostic tests with cutting edge applications leveraging micro uidics, nanotechnology and in- tegrated circuit design. Such technologies allow for automated, rapid turnaround and cost-e ective diagnosis of HIV, where these assays could potentially be read- ily deployed. It is such technology that can potentially change the way diagnostics are performed, as POC technology can be rapidly disseminated, enable decentralized testing and, is user-friendly. A novel smart phone-enabled automated magnetic bead- based platform was developed for a micro uidic ELISA for HIV-1 detection at the POC to meet this demand.
Title: | Development of Smart Phone-based Automated Microfluidic-ELISA For Human Immunodefciency Virus 1. |
109 views
44 downloads |
---|---|---|
Name(s): |
Coarsey, Chad Thomas, author Asghar, Waseem, Thesis advisor Florida Atlantic University, Degree grantor College of Engineering and Computer Science Department of Computer and Electrical Engineering and Computer Science |
|
Type of Resource: | text | |
Genre: | Electronic Thesis Or Dissertation | |
Date Created: | 2017 | |
Date Issued: | 2017 | |
Publisher: | Florida Atlantic University | |
Place of Publication: | Boca Raton, Fla. | |
Physical Form: | application/pdf | |
Extent: | 69 p. | |
Language(s): | English | |
Summary: | The majority of HIV prevalence is found in Sub-Saharan Africa with 36.9 mil- lion living with HIV/AIDS. The cultural implications such as patient non-compliance or denial of available routine medical care can potentially cause limitations on the ef- fectiveness of detecting such virulent pathogens and manage chronic disease. The lack of access to healthcare and further socioeconomic impacts hinder the ability to ade- quately diagnose and treat infection in resource-limited settings. Intervention through diagnosis and treatment helps prevent the spread of transmission, where pre-exposure prophylaxis or active disease prevention measures are not readily available. The cur- rent gold standard for HIV detection is by molecular detection; Reverse-Transcription Polymerase Chain Reaction is widely used that employs cycles of temperature condi- tions that require a thermal cycling platform and typically laboratory space for RNA extraction separate from RT-PCR space required. Serological detection can be ad- vantageous for surveillance and screening, Lateral Flow Assays and Enzyme-Linked Immunosorbent Assay (ELISA) can detect a viral protein (antigen) or antibodies. The ELISA can require at least 12 hours of assay preparation and takes a diagnostic laboratory many resources to run. There is need to develop Point-of-Care (POC) testing that can potentially be used for decentralized testing that can leverage ex- isting technologies such as smart phone capability and routine medical or diagnostic tests with cutting edge applications leveraging micro uidics, nanotechnology and in- tegrated circuit design. Such technologies allow for automated, rapid turnaround and cost-e ective diagnosis of HIV, where these assays could potentially be read- ily deployed. It is such technology that can potentially change the way diagnostics are performed, as POC technology can be rapidly disseminated, enable decentralized testing and, is user-friendly. A novel smart phone-enabled automated magnetic bead- based platform was developed for a micro uidic ELISA for HIV-1 detection at the POC to meet this demand. | |
Identifier: | FA00005945 (IID) | |
Degree granted: | Thesis (M.S.)--Florida Atlantic University, 2017. | |
Collection: | FAU Electronic Theses and Dissertations Collection | |
Note(s): | Includes bibliography. | |
Subject(s): | Dissertations, Academic -- Florida Atlantic University | |
Held by: | Florida Atlantic University Libraries | |
Sublocation: | Digital Library | |
Persistent Link to This Record: | http://purl.flvc.org/fau/fd/FA00005945 | |
Use and Reproduction: | Copyright © is held by the author, with permission granted to Florida Atlantic University to digitize, archive and distribute this item for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires permission of the copyright holder. | |
Use and Reproduction: | http://rightsstatements.org/vocab/InC/1.0/ | |
Host Institution: | FAU | |
Is Part of Series: | Florida Atlantic University Digital Library Collections. |